Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor

Abstract

Retrovirus protease is an enzyme that cleaves gag and gag-pol precursor polyproteins into the functional proteins of mature virus particles1,2. The correct processing of precursor polyproteins is necessary for the infectivity of virus particles: in vitro mutagenesis which introduces deletions into the murine leukaemia virus genome produces a protease-defective virus of immature core form and lacking infectivity3,4. A therapeutic drug effective against disease caused by retrovirus proliferation could likewise interfere with virus maturation. The primary structure has so far been determined for the protease of avian myeloblastosis virus5, and of murine6, feline7 and bovine8 leukaemia viruses. Amino acid sequencing of the retrovirus proteases, either after their purification or from prediction from the nucleotide sequence, shows that they possess the Asp-Thr-Gly sequence characteristic of the aspartyl pro-teinases. In this report we show that retrovirus proteases belong to the aspartyl proteinase group and demonstrate an inhibition by the aspartyl proteinase-specific inhibitor, pepstatin A, on the activity of bovine leukaemia, Moloney murine leukaemia and human T-cell leukaemia virus proteases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Yoshinaka, Y. & Luftig R. B. Cell 12, 709–719 (1977).

    Article  CAS  Google Scholar 

  2. Von der Helm, K. Proc. natn. Acad. Sci. U.S.A. 74, 911–915 (1977).

    Article  ADS  CAS  Google Scholar 

  3. Crawford, S. & Goff, S. P. J. Virol. 53, 899–907 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Katoh, I. et al. Virology 145, 280–292 (1985).

    Article  CAS  Google Scholar 

  5. Sauer, R. T., Allen, D. D. W. & Niall, H. D. Biochemistry 20, 3784–3791 (1981).

    Article  CAS  Google Scholar 

  6. Yoshinaka, Y., Katoh, I., Copeland, T. D. & Oroszlan, S. Proc. natn. Acad. Sci. U.S.A. 82, 1618–1622 (1985).

    Article  ADS  CAS  Google Scholar 

  7. Yoshinaka, Y., Katoh, I., Copeland, T. D. & Oroszlan, S. J. Virol. 55, 870–873 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Yoshinaka, Y., Katoh, I., Copeland, T. D. & Oroszlan, S. J. Virol. 57, 826–832 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Ratner, L. et al. Nature 313, 227–284 (1986).

    Google Scholar 

  10. Inouye, J. et al. Virology 150, 187–195 (1986).

    Article  Google Scholar 

  11. Hiramatsu, K., Nishida, J., Naito, A. & Yoshikura, H. J. gen. Viol. 68, 213–218 (1987).

    Article  CAS  Google Scholar 

  12. Shimotohno, K. et al. Proc. natn. Acad. Sci. U.S.A. 82, 3101–3105 (1985).

    Article  ADS  CAS  Google Scholar 

  13. Moore, R., Dixon, M., Smith, R., Peters, G. & Dickson, C. J. Virol. 61, 480–490 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Yasunaga, T., Sagata, N. & Ikawa, Y. FEBS Lett. 199, 145–150 (1986).

    Article  CAS  Google Scholar 

  15. Miyazaki, H. et al. Proc. natn. Acad. Sci. U.S.A. 81, 5999–6003 (1984).

    Article  ADS  CAS  Google Scholar 

  16. Misono, K., Chang, J. J. & Inagami, T. Proc. natn. Acad. Sci. U.S.A. 79, 4858–4862 (1982).

    Article  ADS  CAS  Google Scholar 

  17. Toh, H., Ono, M., Saigo, K. & Miyata, T. Nature 315, 691 (1985).

    Article  ADS  CAS  Google Scholar 

  18. Umezawa, H. et al. J. Antibiot., Tokyo 23, 259–262 (1970).

    Article  CAS  Google Scholar 

  19. Ragagopalan, T. G., Stein, W. H. & Moore, S. J. biol. Chem. 241, 4295–4297 (1966).

    Google Scholar 

  20. Misono, K. S. & Inagami, T. Biochemistry 19, 2616–2622 (1980).

    Article  CAS  Google Scholar 

  21. Yoshinaka, Y. & Luftig, R. B. Virology 111, 239–250 (1981).

    Article  CAS  Google Scholar 

  22. Aoyagi, T. et al. J. Antibiot., Tokyo 26, 539–541 (1973).

    Article  CAS  Google Scholar 

  23. Yoshinaka, Y. & Luftig, R. B. Biochem. biophys. Res. Commun. 76, 54–56 (1977).

    Article  CAS  Google Scholar 

  24. Foltmann, B. & Pederson, V. B. in Acid Proteases: Structure, Function and Biology (ed. Tang, J.) 3–22 (Plenum, New York, 1977).

    Book  Google Scholar 

  25. Yokosawa, H., Holladay, L. A., Inagami, T., Haas, E. & Murakami, K. J. Biol. Chem. 225, 2498–3502 (1980).

    Google Scholar 

  26. James, M. N. G. & Sielecki, A. R. J. molec. Biol. 163, 299–361 (1983).

    Article  CAS  Google Scholar 

  27. Yoshinaka, Y. & Luftig, R. B. J. gen. Virol. 48, 329–340 (1980).

    Article  CAS  Google Scholar 

  28. Yuasa, Y., Shimojo, H., Aoyagi, T. & Umezawa, H. J. natn. Cancer Inst. 54, 1255–1256 (1975).

    Article  CAS  Google Scholar 

  29. Stephens, R. M., Casey, J. W. & Rice, N. R. Science 231, 589–594 (1986).

    Article  ADS  CAS  Google Scholar 

  30. Power, M. D. et al. Science 231, 1567–1572 (1986).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katoh, I., Yasunaga, T., Ikawa, Y. et al. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature 329, 654–656 (1987). https://doi.org/10.1038/329654a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/329654a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing